These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 27503906)

  • 21. What is the best approach to treating interferon-induced depression in people with multiple sclerosis?
    Patten SB
    J Psychiatry Neurosci; 2001 Jan; 26(1):66. PubMed ID: 11212597
    [No Abstract]   [Full Text] [Related]  

  • 22. Sleep Disturbances in Mood Disorders.
    Rumble ME; White KH; Benca RM
    Psychiatr Clin North Am; 2015 Dec; 38(4):743-59. PubMed ID: 26600106
    [TBL] [Abstract][Full Text] [Related]  

  • 23. People with multiple sclerosis report significantly worse symptoms and health related quality of life than the US general population as measured by PROMIS and NeuroQoL outcome measures.
    Amtmann D; Bamer AM; Kim J; Chung H; Salem R
    Disabil Health J; 2018 Jan; 11(1):99-107. PubMed ID: 28442320
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Distinguishing the Diagnosis and Management of Sleep Disturbance and Sleep Disorders in Multiple Sclerosis.
    Wheeler YS; Heaton K
    Nurs Clin North Am; 2021 Jun; 56(2):157-174. PubMed ID: 34023113
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sleep disorders in patients with multiple sclerosis.
    Čarnická Z; Kollár B; Šiarnik P; Krížová L; Klobučníková K; Turčáni P
    J Clin Sleep Med; 2015 Apr; 11(5):553-7. PubMed ID: 25700869
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of sleep disorders may improve fatigue in multiple sclerosis.
    Veauthier C; Gaede G; Radbruch H; Gottschalk S; Wernecke KD; Paul F
    Clin Neurol Neurosurg; 2013 Sep; 115(9):1826-30. PubMed ID: 23764040
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relative Importance of Baseline Pain, Fatigue, Sleep, and Physical Activity: Predicting Change in Depression in Adults With Multiple Sclerosis.
    Edwards KA; Molton IR; Smith AE; Ehde DM; Bombardier CH; Battalio SL; Jensen MP
    Arch Phys Med Rehabil; 2016 Aug; 97(8):1309-15. PubMed ID: 27016262
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sleep Disorder as a Triggering Factor for Relapse in Multiple Sclerosis.
    Sahraian MA; Rezaali S; Hosseiny M; Doosti R; Tajik A; Naser Moghadasi A
    Eur Neurol; 2017; 77(5-6):258-261. PubMed ID: 28359058
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sleep disturbance and fatigue in mild relapsing remitting multiple sclerosis patients on chronic immunomodulant therapy: an actigraphic study.
    Mendozzi L; Tronci F; Garegnani M; Pugnetti L
    Mult Scler; 2010 Feb; 16(2):238-47. PubMed ID: 20028705
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Factors Associated with Poor Sleep in Older Adults with Multiple Sclerosis.
    Garland SN; Scurrey SRM; Ploughman M;
    Int J Behav Med; 2017 Dec; 24(6):937-945. PubMed ID: 28608172
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fatigue and sleep disturbance in multiple sclerosis.
    Kaynak H; Altintaş A; Kaynak D; Uyanik O; Saip S; Ağaoğlu J; Onder G; Siva A
    Eur J Neurol; 2006 Dec; 13(12):1333-9. PubMed ID: 17116216
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multiple sclerosis. Part 2: ophthalmic issues in MS therapy.
    Pula JH; Javed A
    Curr Opin Ophthalmol; 2009 Nov; 20(6):476-81. PubMed ID: 19816177
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hypnotic use and multiple sclerosis related fatigue: a forgotten confounder.
    Veauthier C
    Sleep Med; 2015 Mar; 16(3):319. PubMed ID: 25660815
    [No Abstract]   [Full Text] [Related]  

  • 34. Improvement of fatigue in patients with rheumatoid arthritis treated with biologics: relationship with sleep disorders, depression and clinical efficacy. A prospective, multicentre study.
    Genty M; Combe B; Kostine M; Ardouin E; Morel J; Lukas C
    Clin Exp Rheumatol; 2017; 35(1):85-92. PubMed ID: 27749229
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of sleep disorder treatment on fatigue in multiple sclerosis.
    Côté I; Trojan DA; Kaminska M; Cardoso M; Benedetti A; Weiss D; Robinson A; Bar-Or A; Lapierre Y; Kimoff RJ
    Mult Scler; 2013 Apr; 19(4):480-9. PubMed ID: 22914848
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sleep disorders in multiple sclerosis in China: clinical, polysomnography study, and review of the literature.
    Chen JH; Liu XQ; Sun HY; Huang Y
    J Clin Neurophysiol; 2014 Aug; 31(4):375-81. PubMed ID: 25083851
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sleep disturbance, depression, and lesion site in patients with multiple sclerosis.
    Clark CM; Fleming JA; Li D; Oger J; Klonoff H; Paty D
    Arch Neurol; 1992 Jun; 49(6):641-3. PubMed ID: 1596200
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Therapeutic compliance of first line disease-modifying therapies in patients with multiple sclerosis. COMPLIANCE Study.
    Saiz A; Mora S; Blanco J;
    Neurologia; 2015 May; 30(4):214-22. PubMed ID: 24484756
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fostering adherence to injectable disease-modifying therapies in multiple sclerosis.
    Lugaresi A; Rottoli MR; Patti F
    Expert Rev Neurother; 2014 Sep; 14(9):1029-42. PubMed ID: 25109614
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fatigue in multiple sclerosis is closely related to sleep disorders: a polysomnographic cross-sectional study.
    Veauthier C; Radbruch H; Gaede G; Pfueller CF; Dörr J; Bellmann-Strobl J; Wernecke KD; Zipp F; Paul F; Sieb JP
    Mult Scler; 2011 May; 17(5):613-22. PubMed ID: 21278050
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.